Résumé
Abstract only
- Titre
- Regorafenib in previously treated metastatic colorectal cancer (mCRC): Analysis of age subgroups in the open-label phase IIIb CONSIGN trial
- Créateurs - sans rôle
- Eric Van Cutsem - University Hospitals Leuven, Leuven, BelgiumFortunato Ciardiello - Second University of Naples, Naples, ItalyMarc Ychou - Institut Regional du Cancer de MontpellierJean Francois Seitz - Aix-Marseille University, Assistance Publique Hôpitaux de Marseille, Marseille, FranceRalf Hofheinz - University Hospital Mannheim, Mannheim, GermanyYull Edwin Arriaga - The University of Texas Southwestern Medical CenterUdit Verma - The University of Texas Southwestern Medical CenterRocio Garcia-Carbonero - Hospital Universitario Doce de Octubre, Madrid, SpainAxel Grothey - Mayo ClinicAshok Miriyala - Bayer Pharma AG, Berlin, GermanyJoachim Kalmus - Bayer Pharma AG, Berlin, GermanyChristian Kappeler - Bayer Pharma AG, Berlin, GermanyAlfredo Falcone - University of PisaAlberto Zaniboni - Fondazione Poliambulanza, Brescia, Italy
- Détails de publication
- Journal of clinical oncology, Vol.34(15_suppl), pp.3524-3524
- Identifiants
- 99140065009311
- Unité académique
- Institut de Recherche en Cancérologie de Montpellier - IRCM
- Langue
- English
- Type de ressource
- Journal article